A microRNA Prognostic Marker Identified in Acute Leukemia
Reporter: Prabodh Kandala, PhD. A study has identified microRNA-3151 as a new independent prognostic marker in certain patients with acute leukemia. The study involves patients with acute myeloid...
View ArticleMedicines in Development for Cancer in 2012: An Excellent Response from...
Reported by: Dr. Venkat S. Karra, Ph.D. Cancer remains the second leading cause of death by disease. Hundreds of new medicines to treat cancer are now being developed for lessening the burden of cancer...
View ArticleGraft-versus-host disease
Graft-versus-host disease Larry H. Bernstein, MD, FCAP, Writer, Curator http://pharmaceuticalintelligence.com/2015/02/19/Graft-versus-host-disease Introduction This piece is a follow up to the article...
View ArticleTreatment of Acute Leukemias
Treatment of Acute Leukemias Author and Curator: Larry H. Bernstein, MD, FCAP 2.4.4 Treatment of Acute Leukemias Treatment of Acute Lymphoblastic Leukemia Ching-Hon Pu, and William E. Evans N Engl J...
View Articletargeting of GSK-3α and GSK-3β
targeting of GSK-3α and GSK-3β Larry H. Bernstein, MD, FCAP, Curator LPBI 4′-((5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl-thio)-methyl)-4-fluorobiphenyl-2-carboxamide by DR...
View Article
More Pages to Explore .....